Pharmaceutical industry, as well as basic science, depend on robust data and scientific rigor for decision making, patent strength and time-to-market for novel patient treatment options. Recent publications challenge the quality of research data, which may impact translationability and predictability of preclinical models. There is a need for simple, sustainable solutions that facilitate data quality.

The objectives of EQIPD are to:

  • enable the development of quality criteria for future preclinical tests
  • develop consensus quality management recommendations in non-regulated R&D to enhance the quality of decisions made based on experimental, exploratory or hypothesis-testing data
  • develop an educational course on scientific quality principles which catalysis the cultural change needed to enhance quality value and sustainability of the findings of preclinical research.

More information on the EQIPD project and the organizations involved can be find here.

Dr. René Bernard Quality Management

+49 30 450 560 388